ArticleEndocrine2025

Correction to: Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study.

Lorenzo Iughetti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.